CSL Behring

KCENTRA

Manufacturer:

CSL Behring

Kcentra HCPCS:

J7168

HCPCS Code Descriptor:

Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity

Category:

J Code

Kcentra NDCs:

63833-0387-02, 63833-0386-02

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Route of Administration:

Multiple Routes

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Kcentra:

KCENTRA is a Hematology drug manufactured by CSL Behring and administered via the Multiple Routes route of administration. The J Code: J7168 is aligned to the drug KCENTRA.

ACCESS PRICING AND MORE BY REGISTERING

J7168 Added Date:

July 1, 2021

J7168 Effective Date:

July 1, 2021

J7168 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Kcentra billing and coding information.
Our team did not identify a source for Kcentra patient assistance information. Please reach out to our team if you feel that this is a mistake.
KCENTRA prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for KCENTRA. Please check back in a few weeks.